ICCC Immucell Corp
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

- Industry (SIC)
- IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (2835)
- Exchange
- XNAS
- Market Cap
- $0.1B
- Employees
- 73
- List Date
- 1987-07-08
- CIK
- 0000811641
- Next Earnings
- 2026-11-12
- Headquarters
- Portland, ME
- Homepage
- https://www.immucell.com
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine cor…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 53.31% | -0.50% | 14.57% | 6.20% | 3.35% | 1.69% | 13.10% |
| Feb | 5.62% | 1.36% | -20.81% | 0.00% | 5.18% | 7.53% | -0.19% |
| Mar | -15.66% | 13.66% | -11.12% | 0.38% | -7.17% | -3.21% | -3.85% |
| Apr | 10.61% | -0.10% | -3.53% | -5.76% | 8.40% | 33.23% | 7.14% |
| May | -6.29% | -16.82% | -3.44% | -15.00% | 20.08% | 17.30% | -0.70% |
| Jun | 0.32% | 5.33% | 0.00% | 10.48% | 2.65% | 3.93% | 3.79% |
| Jul | 8.16% | 2.09% | 5.23% | -8.97% | -3.78% | 0.81% | 0.59% |
| Aug | -8.03% | -18.00% | -13.83% | -6.50% | 6.67% | -11.32% | -8.50% |
| Sep | 8.21% | 2.66% | 17.10% | -3.59% | 1.13% | -1.21% | 4.05% |
| Oct | -3.30% | 8.09% | -3.63% | -1.10% | -5.47% | 2.08%* | -0.55% |
| Nov | 0.63% | -12.55% | -10.98% | 15.08% | -22.06% | -- | -5.98% |
| Dec | -13.33% | -14.08% | 13.62% | 24.70% | 29.75% | -- | 8.13% |
| Total | 28.92% | -29.97% | -22.26% | 9.87% | 33.79% | 54.98% | 12.55% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: ICCC
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers: Strong technical signals, low volatility, and recent earnings growth.
Primary risks: Regulatory setbacks and potential overbought conditions.
Investment thesis: ICCC's current price is oversold, and a short-term rebound is likely. The stock's beta and volatility metrics indicate a relatively stable market environment, which could help contain any potential losses.
Recent news sentiment impact: The recent news headlines have been neutral, with no significant events driving the stock's movement. However, this lack of news-driven volatility has allowed technical signals to take center stage.
Technical Analysis
Trend Direction: Medium-term uptrend (1-3 months)
Support/Resistance Levels: SMA 50 ($10.58) and Bollinger Bands' middle line ($10.03) serve as key support levels. Resistance lies at the upper Bollinger Band ($10.68).
Momentum Signals: RSI interpretation: Neutral range (30-70), indicating a potential consolidation phase.
MACD signal: Bearish, but the MACD histogram is decreasing, suggesting a potential reversal.
Bollinger Bands position: Neutral, with price touching the middle band.
Volume Analysis: Volume has been relatively low, and the OBV indicator suggests a decrease in buying pressure. This could indicate a lack of institutional interest.
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines have been neutral, with no significant events driving the stock's movement.
Sentiment Assessment: Neutral sentiment prevails, as the majority of recent news articles are non-event driven.
Catalyst Identification: No immediate catalysts are identified. However, upcoming earnings reports could provide a short-term catalyst.
Market Narrative: The technical signals suggest a potential rebound, which aligns with the neutral market narrative.
Risk & Volatility Assessment
Beta Interpretation: Low beta (0.37) indicates that ICCC is less volatile than the broader market.
Volatility Regime: Low volatility regime is in place, as the stock's price has been relatively stable.
Options Market Signals: No options data available for analysis.
Downside Protection: Support levels at SMA 50 and Bollinger Bands' middle line provide some downside protection.
Market Context & Positioning
Sector Performance: ICCC is performing similarly to its sector peers, with a relative strength index (RSI) reading of 0.53.
Institutional Activity: Low institutional interest is suggested by the volume analysis and OBV indicator.
Correlation Analysis: The stock's price has been negatively correlated with the market, as indicated by the beta value.
Relative Valuation: ICCC is positioned near its trading range's lower end, suggesting potential for a rebound.
Key Levels & Action Items
Critical Price Levels: SMA 50 ($10.58) and Bollinger Bands' middle line ($10.03) serve as key support levels. Resistance lies at the upper Bollinger Band ($10.68).
Breakout/Breakdown Levels: A breakout above the upper Bollinger Band or a breakdown below the lower Bollinger Band could trigger significant moves.
Time-Sensitive Catalysts: Upcoming earnings reports could provide a short-term catalyst.
Risk Management: Stop-loss levels should be set around $9.50 to manage potential losses. Position sizing considerations suggest using 0.5-1% of total portfolio value for this stock.
Please let me know if you'd like me to continue with the analysis or make any changes!
ICCC Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $1.7M | #2050 of 3138 | +12.7% | 13F | |
| Citadel Hedge fund Ken Griffin | $407K | #4716 of 6285 | +13.5% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ICCC Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ICCC Insider Trading (Form 4)
Latest: 2026-06-22| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Boekhorst Paul Francis Olivier te | President and CEO | Buy (P) | +8,000 | $9.49 | $76.0K | EDGAR |
| 2026-04-16 | Paul R Wainman | Director | Grant (A) | +11,933 opt | — | EDGAR | |
| 2026-04-16 | Gloria F Basse | Director | Grant (A) | +11,933 opt | — | EDGAR | |
| 2026-04-16 | David Scott Tomsche | Director | Grant (A) | +11,933 opt | — | EDGAR | |
| 2026-04-16 | Kathy V Turner | Director | Grant (A) | +17,899 opt | — | EDGAR | |
| 2026-04-14 | Bryan K. Gathagan | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-04-14 | Gloria F Basse | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-04-14 | Steven T. Rosgen | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-04-14 | Bobbi Jo Brockmann | VP of Sales and Marketing | Grant (A) | +5,000 opt | — | EDGAR | |
| 2026-04-14 | Paul R Wainman | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-04-14 | David Scott Tomsche | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-03-24 | Michael F Brigham | Director | Mixed | +948 | $5.95 | $4 | EDGAR |
| 2026-03-23 | Boekhorst Paul Francis Olivier te | President and CEO | Grant (A) | +109,500 opt | — | EDGAR | |
| 2026-01-29 | Timothy C Fiori | Chief Financial Officer | Grant (A) | +120,000 opt | — | EDGAR | |
| 2026-01-29 | Bobbi Jo Brockmann | VP of Sales and Marketing | Grant (A) | +100,000 opt | — | EDGAR |
ICCC Insider Holdings
7 insiders · @ $9.80| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Michael F Brigham | President & CEO | 205,700 | $2.02M | $74.1K | 15 | 2026-03-24 |
| 2 | David Scott Tomsche | Director | 57,460 | $563.1K | $409.9K | 37 | 2026-04-16 |
| 3 | Boekhorst Paul Francis Olivier te | President and CEO | 17,785 | $174.3K | $156.1K | 6 | 2026-06-22 |
| 4 | Bobbi Jo Brockmann | VP of Sales and Marketing | 8,521 | $83.5K | $0 | 9 | 2026-04-14 |
| 5 | Paul R Wainman | Director | 6,269 | $61.4K | $5.0K | 11 | 2026-04-16 |
| 6 | Gloria F Basse | Director | 3,530 | $34.6K | $0 | 6 | 2026-04-16 |
| 7 | Bryan K. Gathagan | Director | 1,000 | $9.8K | $6.3K | 4 | 2026-04-14 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $1.8M | — | 2026-08-31 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $773,283 | — | 2026-08-31 |
| 3 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.01% | $194,864 | $1.3B | 2026-10-08 |
| 4 | DFAT Dimensional U.S. Targeted Value ETF | Nport | 0.00% | $16,742 | — | 2026-10-31 |
| 5 | DCOR Dimensional US Core Equity 1 ETF | Nport | 0.00% | $11,558 | — | 2026-10-31 |
| 6 | DFSU Dimensional US Sustainability Core 1 ETF | Nport | 0.00% | $3,419 | — | 2026-10-31 |
| 7 | DFAC Dimensional U.S. Core Equity 2 ETF | Nport | 0.00% | $650 | — | 2026-10-31 |
| 8 | DXUV Dimensional US Vector Equity ETF | Nport | 0.00% | $24 | — | 2026-10-31 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.